Does diabetes therapy influence the risk of cancer?

被引：253

作者：

Smith, U. ^{[2
]}

Gale, E. A. M. ^{[1
]}

机构：

[1] Southmead Hosp, Med Sch Unit, Bristol BS10 5NB, Avon, England

[2] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden

来源：

DIABETOLOGIA | 2009年 / 52卷 / 09期

关键词：

Cancer; Insulin analogues; Insulin therapy; Metformin; Type; 2; diabetes; INSULIN ANALOGS; COLORECTAL-CANCER; PANCREATIC-CANCER; BREAST-CANCER; IGF-I; MELLITUS; GLARGINE; METAANALYSIS; RECEPTOR; MORTALITY;

D O I：

10.1007/s00125-009-1441-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1699 / 1708

页数：10

共 52 条

[1] Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay [J].

Agin, A. ;

Jeandidier, N. ;

Gasser, F. ;

Grucker, D. ;

Sapin, R. .

DIABETES & METABOLISM, 2007, 33 (03) :205-212

[2] Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis [J].

Barone, Bethany B. ;

Yeh, Hsin-Chieh ;

Snyder, Claire F. ;

Peairs, Kimberly S. ;

Stein, Kelly B. ;

Derr, Rachel L. ;

Wolff, Antonio C. ;

Brancati, Frederick L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (23) :2754-2764

[3] The igf-1 receptor in cancer biology [J].

Baserga, R ;

Peruzzi, F ;

Reiss, K .

INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (06) :873-877

[4] The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level [J].

Ben Sahra, I. ;

Laurent, K. ;

Loubat, A. ;

Giorgetti-Peraldi, S. ;

Colosetti, P. ;

Auberger, P. ;

Tanti, J. F. ;

Le Marchand-Brustel, Y. ;

Bost, F. .

ONCOGENE, 2008, 27 (25) :3576-3586

[5] Safety of insulin glargine [J].

Berger, M .

LANCET, 2000, 356 (9246) :2013-2014

[6]

Black N, 1996, BRIT MED J, V312, P1215

[7] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].

Bowker, SL ;

Majumdar, SR ;

Veugelers, P ;

Johnson, JA .

DIABETES CARE, 2006, 29 (02) :254-258

[8] Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group [J].

Colhoun, H. M. .

DIABETOLOGIA, 2009, 52 (09) :1755-1765

[9] Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults [J].

Coughlin, SS ;

Calle, EE ;

Teras, LR ;

Petrelli, J ;

Thun, MJ .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (12) :1160-1167

[10] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].

Currie, C. J. ;

Poole, C. D. ;

Gale, E. A. M. .

DIABETOLOGIA, 2009, 52 (09) :1766-1777

← 1 2 3 4 5 6 →